Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $249.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Opus Genetics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 4 insiders, $213.8K in total
- Insiders trading
- 4
- Net value
- −$213.8K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Opus Genetics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Magrath George | Chief Executive Officer | 2,048,485 | Sep 11, 2026 | 6 |
| Gallagher Cam | Director | 2,800,111 | Sep 8, 2026 | 4 |
| Gagnon Robert E. | Chief Financial Officer | 556,375 | Sep 8, 2026 | 4 |
| Yerxa Benjamin R | President | 704,106 | Jul 27, 2026 | 4 |
| Schachle Joseph K | Chief Operating Officer | 291,440 | Jul 27, 2026 | 4 |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director, Other: See Remarks | 3,792,171 | May 20, 2026 | 2 |
| Foundation Fighting Blindness, Inc. | Director, Other: See Remarks | 3,792,171 | May 20, 2026 | 2 |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | 188,671 | Apr 27, 2026 | 5 |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | 509,233 | Apr 27, 2026 | 4 |
| Manuso James S J | Director | 317,318 | Apr 22, 2026 | 2 |
| Rodgers Richard J | Director | 343,022 | Apr 22, 2026 | 1 |
| Graves Adrienne L | Director | 127,514 | Apr 22, 2026 | 2 |
| Benton Susan | Director | 243,894 | Apr 22, 2026 | 1 |
| Ainsworth Sean | Director | 321,692 | Apr 22, 2026 | 2 |
| Bennett Jean | Director | 259,019 | Apr 22, 2026 | 2 |
| Hoffmann Bernhard | SVP of Corp. Dev. | 185,446 | Mar 17, 2025 | 0 |
| Jhaveri Nirav S. | Chief Financial Officer | 194,293 | Mar 17, 2025 | 0 |
| Pepose Jay | Director | 180,458 | Jun 13, 2024 | 0 |
| Patel Ronil A. | Chief Business Officer | 90,714 | Jan 12, 2024 | 0 |
| Sooch Mina | President and CEO | 430,501 | Jan 12, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)4:05 PM ET | Sep 3 | 5 days | Gagnon Robert E.Chief Financial Officer | SSale | −28.0K | $4.54 | −$127.2K | −4.8%556.4K after | |
| Jul 27, 2026 (view filing)4:08 PM ET | Jul 23 | 4 days | Yerxa Benjamin RPresident | SSale | −7.43K | $2.97 | −$22.1K | −1.0%704.1K after | |
| Jul 27, 2026 (view filing)4:07 PM ET | Jul 23 | 4 days | Schachle Joseph KChief Operating Officer | SSale | −4.64K | $2.94 | −$13.7K | −1.6%291.4K after | |
| Jul 27, 2026 (view filing)4:07 PM ET | Jul 23 | 4 days | Magrath GeorgeChief Executive Officer | SSale | −9.47K | $2.95 | −$27.9K | −0.5%1.73M after | |
| Jul 27, 2026 (view filing)4:06 PM ET | Jul 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.78K | $2.95 | −$22.9K | −1.3%584.4K after | |
| May 20, 2026 (view filing)7:29 PM ET | May 18 | 2 days | Foundation Fighting Blindness Retinal Degeneration Fund and 1 otherDirector, Other: See Remarks | SSale | −1.70M | $4.35 | −$7.39M | −31.0%3.79M after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Yerxa Benjamin RPresident | SSale | −7.47K | $5.24 | −$39.1K | −1.0%711.5K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Schachle Joseph KChief Operating Officer | SSale | −4.70K | $5.22 | −$24.5K | −1.6%296.1K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Zaremba Rabourn AmyHead of Fin. Quality Assurance | SSale | −1.64K | $5.20 | −$8.53K | −0.9%188.7K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Magrath GeorgeChief Executive Officer | SSale | −9.51K | $5.22 | −$49.6K | −0.5%1.74M after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Jayagopal AshwathChief Scientific & Dev. Ofc. | SSale | −7.54K | $5.19 | −$39.1K | −1.5%509.2K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.84K | $5.18 | −$40.6K | −1.3%592.2K after | |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Schachle Joseph KChief Operating Officer | SSale | −3.72K | $5.25 | −$19.5K | −1.2%300.8K after | |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Zaremba Rabourn AmyHead of Fin. Quality Assurance | SSale | −2.82K | $5.25 | −$14.8K | −1.5%190.3K after | |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Magrath GeorgeChief Executive Officer | SSale | −24.4K | $5.21 | −$127.3K | −1.4%1.75M after | |
| Mar 18, 2026 (view filing) | Mar 16 | 2 days | Jayagopal AshwathChief Scientific & Dev. Ofc. | SSale | −3.72K | $5.12 | −$19.0K | −0.7%516.8K after | |
| Dec 31, 2025 (view filing) | Dec 29 | 2 days | Gallagher CamDirector | PPurchase | +81.0K | $1.98 | +$160.4K | +4.5%1.89M after | |
| Dec 31, 2025 (view filing) | Dec 29 | 2 days | Gallagher CamDirector | PPurchase | +83.0K | $1.97 | +$163.5K | New position83.0K after | |
| Dec 11, 2025 (view filing)5:35 PM ET | Dec 9 | 2 days | Foundation Fighting Blindness Retinal Degeneration Fund and 1 otherDirector, Other: See Remarks | SSale | −4.00M | $2.15 | −$8.60M | −42.1%5.49M after | |
| Dec 30, 2024 (view filing) | Dec 26 | 4 days | Magrath GeorgeChief Executive Officer | PPurchase | +100.0K | $0.98 | +$98.0K | +20.0%599.1K after | |
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Yerxa Benjamin RPresident | PPurchase | +10.0K | $0.98 | +$9.80K | +3.0%342.8K after | |
| Nov 19, 2024 (view filing) | Nov 15-18 | 4 days | Magrath GeorgeChief Executive Officer | PPurchase | +100.0K | $1.01 | +$101.1K | +25.4%492.9K after | 2 lots |
| May 24, 2024 (view filing) | May 22 | 2 days | Jayagopal AshwathChief Scientific & Dev. Ofc. | PPurchase | +3.50K | $1.77 | +$6.20K | +4.7%78.5K after | |
| May 21, 2024 (view filing) | May 17 | 4 days | Magrath GeorgeChief Executive Officer | PPurchase | +5.00K | $1.75 | +$8.75K | +1.2%430.0K after | |
| Mar 25, 2024 (view filing) | Mar 21 | 4 days | Schachle Joseph KChief Operating Officer | PPurchase | +2.00K | $2.05 | +$4.10K | New position2.00K after | |
| Mar 25, 2024 (view filing) | Mar 21 | 4 days | Jhaveri Nirav S.Chief Financial Officer | PPurchase | +10.0K | $2.10 | +$21.0K | +7.1%150.0K after | |
| Mar 20, 2024 (view filing) | Mar 18 | 2 days | Magrath GeorgeChief Executive Officer | PPurchase | +25.0K | $1.96 | +$49.0K | +6.3%425.0K after | |
| May 24, 2022 (view filing) | May 20 | 4 days | Manuso James S JDirector | PPurchase | +5.00K | $1.99 | +$9.95K | +30.2%21.6K after | |
| May 23, 2022 (view filing) | May 19-20 | 4 days | Sooch MinaPresident and CEO | PPurchase | +25.0K | $2.05 | +$51.1K | +6.2%425.0K after | 2 lots |
| Dec 14, 2021 (view filing) | Dec 13 | 1 day | Pepose JayDirector | PPurchase | +8.25K | $3.65 | +$30.1K | +56.0%23.0K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Manuso James S JDirector | PPurchase | +2.00K | $3.50 | +$7.00K | +13.7%16.6K after | |
| Sep 15, 2021 (view filing) | Sep 13 | 2 days | Pepose JayDirector | PPurchase | +12.6K | $4.75 | +$60.0K | +597.8%14.7K after | |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Benton SusanDirector | PPurchase | +20.0K | $4.57 | +$91.4K | +503.0%24.0K after |